Venous thromboembolism recurrence prevention
The sponsor’s clinical research is centered on preventing recurrence after a first episode of venous thromboembolism, with attention to patients who have experienced deep vein thrombosis or pulmonary embolism.
- Secondary prevention after first VTE
- Deep vein thrombosis
- Pulmonary embolism
The therapeutic interest is focused on reducing the risk of relapse in this cardiovascular and thromboembolic setting.
Elderly patient care
Current research activity is directed toward older adults, especially patients around 75 years of age who have had a recent thrombotic event and require strategies tailored to age-related clinical vulnerability.
- Older adults
- Age-related thrombosis risk
- Post-event prevention
This area reflects a specific interest in geriatric thrombosis management and recurrence prevention in a high-risk population.
Antithrombotic therapy evaluation
The sponsor funds research on an antithrombotic treatment approach aimed at lowering relapse risk while maintaining an acceptable safety profile in patients with prior venous thromboembolism.
- Antithrombotic therapy
- Bleeding safety
- Recurrence reduction
Clinical interest extends to balancing protection from recurrent thrombosis with the risk of major bleeding.
Thrombosis and vascular medicine
Its research landscape is embedded in vascular medicine, with emphasis on disorders of clot formation and the prevention of subsequent thrombotic events after an initial diagnosis.
- Thrombosis
- Vascular disease
- Clot recurrence
The funded trial activity aligns with clinical questions in hemostasis and long-term management after venous clotting events.
